Active Surveillance of Papillary Thyroid Microcarcinoma (PMCAS)
Sponsor: Cedars-Sinai Medical Center
This NA trial investigates Papillary Thyroid Microcarcinoma and is currently actively recruiting participants. Cedars-Sinai Medical Center leads this study, which shows 17 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
17 versions recorded-
Oct 2025 — Present [monthly]
Recruiting NA
-
Apr 2025 — Oct 2025 [monthly]
Recruiting NA
-
Sep 2024 — Apr 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 12 earlier versions
-
Nov 2023 — May 2024 [monthly]
Recruiting NA
-
Apr 2023 — Nov 2023 [monthly]
Recruiting NA
-
Sep 2022 — Apr 2023 [monthly]
Recruiting NA
-
Jan 2022 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Jan 2022 [monthly]
Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jul 2020 [monthly]
Recruiting NA
-
Aug 2019 — Feb 2020 [monthly]
Recruiting NA
-
Feb 2019 — Aug 2019 [monthly]
Recruiting NA
-
Jul 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .